lucentis patient portal

How long does it take for Lucentis to work?

The Port Delivery System continually releases Lucentis into the eye for a 24 week period and can be refilled. Lucentis (ranibizumab) is an effective anti-VEGF medication that is currently delivered only intravitreal injection.

What is Lucentis (ranibizumab)?

Lucentis (ranibizumab) is an effective anti-VEGF medication that is currently delivered only intravitreal injection. Repeated injections are usually required to treat diabetic retinopathy, wet macular degeneration and retinal vascular occlusions.

What are the possible side effects of Lucentis?

In the LUCENTIS Phase III clinical trials, the most common ocular side effects included conjunctival hemorrhage, eye pain, vitreous floaters, and increased intraocular pressure. The most common non-ocular side effects included nasopharyngitis, anemia, nausea, and cough.

What is my Patient Solutions ®?

My Patient Solutions ®. My Patient Solutions is an online tool to help you enroll and manage your Genentech Access Solutions service requests. It allows you the flexibility to work with Genentech Access Solutions when it’s convenient for you.

Enrolling in the Genentech Patient Foundation

The Genentech Patient Foundation gives free Genentech treatment to people who don't have insurance or who have financial concerns and meet eligibility criteria. Two forms are needed to enroll in the Genentech Patient Foundation:

Considerations for Composing a Letter of Medical Necessity

This guide provides tips to help you draft a letter of medical necessity. A sample letter is also included for your reference. Use the links below to find additional information to enclose in your letter.

Considerations for Composing a Sample Appeal Letter

This guide provides tips to help you draft an appeal letter. A sample letter is also included for your reference. Use the links below to find additional information to enclose in your letter.

Fax Cover Letter

Use this cover sheet when faxing documents to LUCENTIS Access Solutions.

Repeated Injections

Most treatments require monthly injections intermixed with extra visits to the office for monitoring both treatment and the disease. Treatment requires many trips to the office.

How the Port Delivery System Works

At first, the tiny reservoir must be surgically implanted. The PDS then will release Ranibizumab (Lucentis) continuously until refill is needed, about 24 weeks later. Different strengths and amounts of medication are part of the trial.

Port Delivery System

Roche Pharmaceuticals is testing the proprietary system. It is presently in Phase 3 clinical trials and is not yet available to the general public for use. The “Archway” study is comparing the effectiveness of the PDS vs. patients receiving monthly intravitreal injections of Lucentis.